The intracellular renin-angiotensin system: Implications in cardiovascular remodeling

Current Opinion in Nephrology and Hypertension

Volumn 17, Issue 2, 2008, Pages 168-173

  Kumar, Rajesh ^a   Singh, Vivek P ^a   Baker, Kenneth M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Bldg 205 ^*  (United States)

Author keywords

Angiotensin II; Diabetes; Intracrine; Renin angiotensin system; Type 1 angiotensin

Indexed keywords

ANGIOTENSIN II; CATHEPSIN D; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DIABETES MELLITUS; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CARDIOVASCULAR AGENTS; EXTRACELLULAR FLUID; FIBROSIS; HUMANS; INTRACELLULAR FLUID; MYOCARDIUM; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 39149119226     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3282f521a8     Document Type: Review

References (55)

1. Re RN. Cellular biology of the renin-angiotensin systems. Arch Intern Med 1984; 144:2037-2041.
2. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab 2007; 18:208-214. An informative current review that summarizes evidence for the intracellular presence of RAS components, intracellular synthesis of Ang II, biological functions and pathophysiological significance of the iRAS.
3. Re RN. The intracellular renin angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol Heart Circ Physiol 2007; 293:H905-H906. This editorial provides an overview of the iRAS.
4. Re RN, Cook JL. Mechanisms of disease: intracrine physiology in the cardiovascular system. Nat Clin Pract Cardiovasc Med 2007; 4:549-557. A review that describes the intracrine role of several components of the RAS and other proteins in cardiovascular development and angiogenesis.
5. Robertson AL Jr, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science 1971; 172:1138-1139.
6. Singh VP, Le B, Bhat VB, et al. High glucose induced regulation of intracellular angiotensin II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol Heart Circ Physiol 2007; 293:H939-H948. This study provides the first definitive evidence of intracellular synthesis of Ang II in neonatal rat cardiac myocytes.
7. Lavrentyev EN, Estes AM, Malik KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res 2007; 101:455-464. This study demonstrates intracellular synthesis of Ang II in vascular smooth muscle cells, and involvement of cathepsin D and vascular chymase in iAng II generation.
8. Vidotti DB, Casarini DE, Cristovam PC, et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 2004; 286:F1039-F1045.
9. Pepperell JR, Nemeth G, Yamada Y, et al. Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis. Am J Physiol Endocrinol Metab 2006; 291:E221-E233.
10. 1 receptors in the nuclear fraction of renal cortex and medulla, and regulation in hypertension.
11. Kumar R, Baker KM, Pan J. Cardiac and vascular renin-angiotensin systems. In: Carey RM, editor. Hypertension and hormone mechanisms, 2nd ed. Totowa: Humana Press; 2007. pp. 23-42.
12. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292:C82-C97.
13. 1 receptors and control of blood pressure: the kidney and more. Trends Cardiovasc Med 2007; 17:30-34.
14. Re RN. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med 2004; 1:42-47.
15. Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005; 14:125-131.
16. Javeshghani D, Sairam MR, Neves MF, et al. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension. J Hypertens 2006; 24:1365-1373. This study demonstrates blood pressure-independent effects of Ang II in endothelial dysfunction and cardiac fibrosis.
17. Bader M. Role of the local renin-angiotensin system in cardiac damage: a minireview focussing on transgenic animal models. J Mol Cell Cardiol 2002; 34:1455-1462.
18. Reudelhuber TL, Bernstein KE, Delafontaine P. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension 2007; 49:1196-1201. A critical review that reanalyzes the evidence of a direct role of Ang II in cardiac hypertrophy.
19. 1 receptors in the development of Ang II-induced hypertension and cardiac hypertrophy.
20. Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005; 115:1092-1099.
21. Malhotra R, Sadoshima J, Brosius FC 3rd, Izumo S. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res 1999; 85:137-146.
22. Kijima K, Matsubara H, Murasawa S, et al. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res 1996; 79:887-897.
23. Oliviero P, Chassagne C, Kolar F, et al. Effect of pressure overload on angiotensin receptor expression in the rat heart during early postnatal life. J Mol Cell Cardiol 2000; 32:1631-1645.
24. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999; 33:340-346.
25. Danser AH. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 2003; 35:759-768.
26. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 2007; 369:1208-1219.
27. Turnbull F, Neal B, Pfeffer M, et al. Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens 2007; 25:951-958.
28. Steckelings UM, Rettig R, Unger T. Angiotensin in the kidney: a key to understanding hypertension? Cell Metab 2007; 5:7-8. This preview discusses the (lack of) relevance of Ang II-induced hypertension in the pathogenesis of human primary hypertension.
29. Ichihara A, Kaneshiro Y, Takemitsu T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47:894-900. This study demonstrates the importance of locally produced Ang II, independent of circulating Ang II and blood pressure, in hypertension-induced cardiac fibrosis.
30. Ernsberger P, Koletsky RJ. Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect? Curr Opin Pharmacol 2007; 7:140-145.
31. Peng H, Carretero OA, Vuljaj N, et al. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation 2005; 112:2436-2445.
32. Kang N, Walther T, Tian XL, et al. Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis. J Mol Med 2002; 80:359-366.
33. Xiao HD, Fuchs S, Campbell DJ, et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 2004; 165:1019-1032.
34. Van Kats JP, Methot D, Paradis P, et al. Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J Biol Chem 2001; 276:44012-44017.
35. Mazzolai L, Nussberger J, Aubert JF, et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998; 31:1324-1330.
36. Guo X, Saini HK, Wang J, et al. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system. Expert Rev Cardiovasc Ther 2005; 3:717-732.
37. Xu J, Carretero OA, Lin CX, et al. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. Am J Physiol Heart Circ Physiol 2007; 293:H1900-H1907. This study demonstrates that stimulation of a local, endogenous RAS, rather than exogenous extracellular Ang II, is important in the regulation of cardiac function and remodeling.
38. Chai W, Danser AH. Is angiotensin II made inside or outside of the cell? Curr Hypertens Rep 2005; 7:124-127.
39. Singh VP, Baker KM, Kumar R. Evidence of intracellular synthesis of angiotensin II in cardiac myocytes and fibroblasts. Hypertension 2006; 48:e42.
40. Singh R, Leehey DJ. Effect of ACE inhibitors on angiotensin II in rat mesangial cells cultured in high glucose. Biochem Biophys Res Commun 2007; 357:1040-1045. This study demonstrates high glucose-induced and chymase-mediated iAng II synthesis in mesangial cells.
41. Miyazaki M, Takai S. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase. J Pharmacol Sci 2006; 100:391-397.
42. Bacani C, Frishman WH. Chymase: a new pharmacologic target in cardiovascular disease. Cardiol Rev 2006; 14:187-193.
43. Koka V, Wang W, Huang XR, et al. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. Circulation 2006; 113:1353-1360. This human study describes a mechanism of chymase induction in coronary and renal arteries of diabetic patients and its importance in Ang II synthesis.
44. Li M, Liu K, Michalicek J, et al. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J Clin Invest 2004; 114:112-120.
45. Booz GW, Conrad KM, Hess AL, et al. Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology 1992; 130:3641-3649.
46. Re R, Parab M. Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci 1984; 34:647-651.
47. Re RN, Vizard DL, Brown J, Bryan SE. Angiotensin II receptors in chromatin fragments generated by micrococcal nuclease. Biochem Biophys Res Commun 1984; 119:220-227.
48. De Mello WC. Cardiac intracrine renin angiotensin system. Part of genetic reprogramming? Regul Pept 2006; 133:10-12.
49. 1 receptor, by both extracellular and intracellular Ang II and translocation of the cleaved product into the nucleus.
50. Baker KM, Chernin MI, Schreiber T, et al. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 2004; 120:5-13.
51. Thomas WG, Brandenburger Y, Autelitano DJ, et al. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 2002; 90:135-142.
52. 1 receptor is not a requirement for iAng II actions.
53. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87:1123-1132.
54. Clausmeyer S, Reinecke A, Farrenkopf R, et al. Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology 2000; 141:2963-2970.
55. 2 receptors.